SITC 2025: Cell Therapy Post-Conference Report

What’s Inside the Report?

Here’s a clear, streamlined look at the most impactful cell therapy developments showcased at SITC 2025, all captured in a single, easy-to-navigate analysis:

• A complete breakdown of 82 cell therapy abstracts, clearly organized across clinical, preclinical, and trial outline categories
• Concise visuals summarizing phase distribution across the 46 trials with clinical data
• An overview of the most widely investigated therapeutic classes, including why CAR and TCR therapies dominated this year’s landscape
• Analysis of top targets, such as the resurgence of CD19 and the notable decline in PRAME interest compared to 2024
• High-value summaries of clinical performance trends, preclinical engineering innovations, and early-stage activity across solid and hematologic indications
• Analyst-curated insights highlighting emerging modalities, novel engineering strategies, target shifts, and areas where companies are intensifying their research focus

Whether you’re tracking competitive movement, evaluating scientific trajectories, informing BD and CI planning, or simply staying current with the meeting’s most relevant findings, this report distills SITC’s complex data into the insights that matter most – without the time-intensive review of every abstract.